CAR-T Cell Therapy
Chimeric Antigen Receptor T-cell therapy — genetically engineering your own immune cells to recognize and destroy cancer.
What is CAR-T Cell Therapy?
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a groundbreaking form of immunotherapy that uses a patient's own genetically modified immune cells to fight cancer. T cells are extracted from the patient's blood, engineered in a laboratory to produce special receptors on their surface called chimeric antigen receptors (CARs), and then infused back into the patient.
These modified T cells can now recognize and attach to specific proteins on the surface of cancer cells, effectively targeting and killing them with remarkable precision.
How It Works
Collection
T cells are collected from the patient's blood through a process called leukapheresis.
Engineering
T cells are genetically modified in the lab to express CARs that target cancer-specific antigens.
Expansion
Modified CAR-T cells are multiplied to create millions of cancer-fighting cells.
Infusion
The engineered cells are infused back into the patient to seek and destroy cancer cells.
Treatable Conditions
Why Choose China for CAR-T?
- China has the second-largest number of CAR-T clinical trials globally
- Multiple approved CAR-T products with proven efficacy
- Significantly lower cost compared to US and Europe (often 1/3 to 1/5 of the price)
- Top-tier hospitals with extensive CAR-T treatment experience
- Access to next-generation CAR-T therapies in clinical trials
Quick Facts
- Type:Cell-based immunotherapy
- Duration:3-6 weeks total process
- Hospital Stay:2-4 weeks monitoring
- Success Rate:70-90% remission in eligible patients
Ready to Learn More?
Our medical team can help assess if CAR-T therapy is right for your condition.
Free ConsultationRelated Treatments
Start Your Healing Journey Today
Our expert team provides free consultation to craft your personalized treatment plan.